MPG.eBooks - Description: Ledipasvir/Sofosbuvir (Harvoni)

Cover Image

Read Now

Ledipasvir/Sofosbuvir (Harvoni) for the treatment of chronic hepatitis C virus (CHC) G1 infection in adults

The objective of this report was to perform a systematic review of the beneficial and harmful effects of ledipasvir plus sofosbuvir (LDV/SOF) for the treatment of chronic hepatitis C virus (HCV) G1 infection in adults

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2015, 2015
Series:	Common drug review
Subjects:	Fluorenes / Therapeutic Use Uridine Monophosphate / Analogs & Derivatives Antiviral Agents / Therapeutic Use Benzimidazoles / Therapeutic Use Hepatitis C, Chronic / Drug Therapy
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK362643
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The objective of this report was to perform a systematic review of the beneficial and harmful effects of ledipasvir plus sofosbuvir (LDV/SOF) for the treatment of chronic hepatitis C virus (HCV) G1 infection in adults
Physical Description:	1 PDF file illustrations